Hologic Stock News

DAVOS, Switzerland--(BUSINESS WIRE)---- $HOLX #HGWHI--New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide.

Hologic, Inc. is down approximately 20% from recent highs despite strong quarterly results. The company continues to grow organically and via a series of 'bolt-on' acquisitions.  Management also recently added significantly to the company's stock buyback authorization. An updated analysis around Hologic, Inc. follows in the paragraphs below.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #JPMC25--Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #gynesonics--Hologic Completes Acquisition of Gynesonics, Inc.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #H5N1--Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #USPSTF--Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines.